Newsstand Menu

LabDish Blog

Anya Shah
Anya Shah in the lab.

A survivor’s path to cancer research

Print Friendly, PDF & Email
When I was eight years old, I was diagnosed with acute lymphoblastic leukemia (ALL) and underwent about two and a half years of treatment. Before having cancer, my hope for the future was to become the President of the United States. But after having cancer, my priorities have changed. I realized that I wanted to become a pediatric oncologist and treat other children with cancer, because I know what it is like to be in their shoes. I am an incoming eleventh-grader and have been in remission for about six years now. I am part of the speaker’s bureau at City of Hope, a cancer research hospital in southern California where I was treated. As a speaker, I share my success story to help raise funds for better care and more research.

Research holds a prominent role because it helps us find and develop new cures or methods, and possible causes, to increase survival rates. I have been given the opportunity of furthering my passion for research by interning this summer at Cold Spring Harbor Laboratory and being mentored by Sofya Polyanskaya, a Ph.D. student, who taught me everything from running an agarose gel to utilizing CRISPR-Cas9 to perform targeted gene editing in leukemia cells. I am working with human acute myeloid leukemia (AML) cells derived from real patients, which makes my research all the more relevant for the context of human disease.

Anya Shah and Sofya Polyanskaya
Anya Shah with her mentor Sofya Polyanskaya

This has been such a unique learning experience, especially since my background consists mainly of high school biology and chemistry classes. When I had a meeting with Chris Vakoc, MD, Ph.D., the PI of the Vakoc laboratory, I recollect his amazement that the same genetic code governs all living organisms, from trees to humans. The endless mysteries of nature and curiosity drives him to search for new questions and work toward new discoveries.

Along the famous lines of the Star Trek franchise “explore strange new worlds… and go where no one has gone before,” Chris described how he is motivated by his urge to discover the unknown and to find out something that no one else knows. For my part, I am motivated by my personal fight with cancer as well as exploring new horizons.

I have always been curious as to how leukemia cells can multiply so rapidly and become so powerful. During my internship, my mentor Sofya has helped me conduct a project regarding specific genes editing on AML cells proliferation. In that process, we turn off certain genes we presume important to AML cells’ survival and see whether these cells die as a result. We hypothesized that certain mitotic kinases, enzymes that are essential in the process of cell division, could present attractive drug targets for cancer therapy.

For my project, I set out to assess AML cells’ dependency on these kinases. Using the CRISPR-Cas9 system, we were able to introduce double-strand breaks into the cancer cell genome at specific sequences. These double-strand breaks are often repaired inaccurately, which often leads to a premature stop signal for gene transcription. As a result, the correct protein cannot be synthesized. Therefore, the gene is turned off and can no longer perform its function. If AML cells are truly dependent on our genes of interest, they will fail to proliferate upon turning off these genes.

Cancer research requires creativity, patience, and persistence, and this research holds a vital role in the future of medicine and science. It has already helped save lives and will continue to do so. Being exposed to the process of scientific research during my time at the Lab motivates me to want to come back and continue exploring and learning. Working in a cancer research lab has provided me with so much knowledge and insight into research, as well as a possible future career pathway for which I am beyond grateful for.

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup